| Family: | Invesco |
| Name: | Invesco S&P International Developed Quality ETF |
| Inception Date: | 13-Jun-2007 |
| Termination Date: | |
| Investment Objective: | The Invesco S&P International Developed Quality ETF (Fund) is based on the S&P Quality Developed ex-U.S. LargeMidCap Index (Index). The Fund generally will invest at least 90% of its total assets in common stocks that comprise the Index. The Index tracks the performance of stocks in the S&P Developed ex-U.S. LargeMidCap Index that have the highest quality score, which is calculated based on three fundamental measures, return on equity, accruals ratio and financial leverage ratio. The Fund and the Index are rebalanced and reconstituted semi-annually on the third Friday of June and December. |
| Prospectus | |
| Top 10 Holdings | ||
| ASML HOLDING NV EUR 0.09 | ASML | 5.8133% |
| SK HYNIX INC KRW 5000.0 | 000660 | 5.1610% |
| NOVARTIS AG CHF 0.49 | NOVN | 4.5920% |
| ROCHE HOLDING AG CHF 0.001 | ROP | 4.2322% |
| ADVANTEST CORP NPV | 6857 | 2.9913% |
| ROLLS-ROYCE HOLDINGS PLC 20P | RR/ | 2.7080% |
| ALLIANZ SE NPV(REGD)(VINKULIERT) | ALV | 2.6621% |
| SAFRAN SA EUR 0.2 | SAF | 2.5840% |
| UNILEVER PLC 0.031111P | ULVR | 2.3810% |
| GSK PLC | GSK | 2.3637% |
| Top 10 Holdings Weight: | 35.5% |
| Number of Holdings: | 208 |
| Shares Outstanding: | 18,700,000 |
| Total Net Assets: | 640,475,000 |
| NAV: | 34.23 |
| Net Expense Ratio: | 0.29% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Large & Mid Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | International |
